Questions with no answer at all. Not questions with no accepted answer — those are elsewhere.
Details up front: a GLP-1 receptor agonist · 2–8 °C · seven days. This is a planning question. I know what my options are; I do not know how to weigh them. What I…
Setup, so nobody has to ask: headache · cagrilintide. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My…
Details up front: racemisation · 2–8 °C. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring answer. I would…
Conditions: 98.4% · oral semaglutide · BCH. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan I write…
What I have: CPC · an HPLC purity test. I want the working, not the result — I need to be able to redo it with different numbers. I care about the precision as well…
The case in front of me: QSC · mazdutide. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline. I…
Stated plainly: a low-dead-space syringe · 2 mg · 2 mg/mL. The units are where I keep going wrong, so please be explicit about them. I have sanity-checked the order…
What I am working with: semaglutide · twenty-eight days. Please show the division. I want to check my own against yours. I would like the general form as well as the…
What I have: mazdutide · 30 °C. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I am interested in…
The specifics, since they change the answer: Janoshik · Flourishglobal Peptide Biotech. This is presented as though it settles something, and I am not convinced it…
I would rather spend on verification than on volume. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan…
Transit was eleven days with two scanning gaps, so the thermal history is partly inferred. I have read the obvious sources and they disagree with each other, so I…
For reference: reflux · five · a GLP-1 receptor agonist. I have read the obvious sources and they disagree with each other, so I would rather ask people who have…
What I am working with: a 27G needle · cagrilintide · 2.5 mg/mL. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I…
What I am working with: orforglipron · 2–8 °C · forty-two days. I am trying to build something sustainable rather than something thorough that I will abandon. I have…
The case in front of me: lot-specific certificate · JEEP. I am trying to build something sustainable rather than something thorough that I will abandon. I have…
Stated plainly: dulaglutide · two weeks · 2–8 °C. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I would…
What I have: a 31G needle · dulaglutide · 5 mg/mL. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
Setup, so nobody has to ask: Chengdu · Germany. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
For reference: a U-100 insulin syringe · 2 mg · 8 mg/mL. I would rather understand the derivation than memorise the outcome. Two people I asked gave two answers that…
The particulars: AST · survodutide. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping rules, not…
What I have: method section · HJ. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably comfortable with…
The particulars: reflux · semaglutide · STEP 1. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
Setup, so nobody has to ask: orforglipron · 12 mg. The units are where I keep going wrong, so please be explicit about them. I have sanity-checked the order of…